Other studies examining tumour mutations by race have shown Black men have higher mutation frequency in actionable genes (e.g. epidermal growth factor receptor [EGFR], v‐erb‐b2 avian erythroblastic leukemia viral oncogene homolog 2 [ERBB2], breast cancer gene 1/2 [BRCA1/2] and phosphatidylinositol‐4,5‐bisphosphate 3‐kinase [PIK3CA]) in primary and metastatic PCa and in androgen receptor and DNA repair genes in metastatic PCa compared with White and Asian men.15, 16. The gene discussed is AR; the disease is neoplasm.